Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose inhaled and nebulized budesonide added to standard treatment in children with acute asthma
TCTR20230427001Unknown
- Sponsor
- Thammasat University
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of budesonide in asthma, sponsored by Thammasat University. Status: unknown.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on TCTR20230427001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230427001.